4//SEC Filing
Norton Evan 4
Accession 0001209191-21-028329
CIK 0001528287other
Filed
Apr 25, 8:00 PM ET
Accepted
Apr 26, 5:18 PM ET
Size
7.7 KB
Accession
0001209191-21-028329
Insider Transaction Report
Form 4
NeuroPace IncNPCE
Norton Evan
Director
Transactions
- Conversion
Common Stock
2021-04-26+3,454,422→ 4,042,657 total(indirect: See Footnote) - Conversion
Series B' Preferred Stock
2021-04-26−3,454,422→ 0 total(indirect: See Footnote)Exercise: $0.00→ Common Stock (3,454,422 underlying)
Footnotes (2)
- [F1]Shares are held by Accelmed Partners II LP. Accelmed Partners II, LLC ("Accelmed LLC") is the general partner of Accelmed Partners II GP, L.P., which is the general partner of Accelmed Partners II LP. Uri Geiger is the managing partner of Accelmed LLC and has sole voting and dispositive power with respect to the shares held by Accelmed Partners II LP. Mr. Norton, a member of our board of directors, is a General Partner at Accelmed LLC.
- [F2]Each share of Preferred Stock automatically converted on a 1-for-1 basis into Common Stock upon the closing of the Issuer's initial public offering, for no additional consideration. The Preferred Stock has no expiration date.
Documents
Issuer
NeuroPace Inc
CIK 0001528287
Entity typeother
Related Parties
1- filerCIK 0001856303
Filing Metadata
- Form type
- 4
- Filed
- Apr 25, 8:00 PM ET
- Accepted
- Apr 26, 5:18 PM ET
- Size
- 7.7 KB